Correlation Between Skechers USA and Summit Therapeutics

Can any of the company-specific risk be diversified away by investing in both Skechers USA and Summit Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Skechers USA and Summit Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Skechers USA and Summit Therapeutics PLC, you can compare the effects of market volatilities on Skechers USA and Summit Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Skechers USA with a short position of Summit Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Skechers USA and Summit Therapeutics.

Diversification Opportunities for Skechers USA and Summit Therapeutics

-0.3

Correlation Coefficient

Skechers USA  Summit Therapeutics

Very good diversification

The 3 months correlation between Skechers and Summit is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Skechers USA and Summit Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Summit Therapeutics PLC and Skechers USA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Skechers USA are associated (or correlated) with Summit Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Summit Therapeutics PLC has no effect on the direction of Skechers USA i.e., Skechers USA and Summit Therapeutics go up and down completely randomly.

Pair Corralation between Skechers USA and Summit Therapeutics

Considering the 90-day investment horizon Skechers USA is expected to generate 0.44 times more return on investment than Summit Therapeutics. However, Skechers USA is 2.26 times less risky than Summit Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Summit Therapeutics PLC is currently generating about -0.03 per unit of risk. If you would invest  6,310  in Skechers USA on September 21, 2024 and sell it today you would earn a total of  319.00  from holding Skechers USA or generate 5.06% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Skechers USA  vs.  Summit Therapeutics PLC

Skechers USA

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Skechers USA are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent forward-looking signals, Skechers USA may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Summit Therapeutics PLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Summit Therapeutics PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's primary indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with Skechers USA and Summit Therapeutics

The main advantage of trading using opposite Skechers USA and Summit Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Skechers USA position performs unexpectedly, Summit Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Summit Therapeutics will offset losses from the drop in Summit Therapeutics' long position.

The idea behind Skechers USA and Summit Therapeutics PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.